Overall rank by patents
#8,329
Across all tracked assignees
USPTO PatentsView assignee record - 38 granted patents across 16 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F04C (ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS ; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS).
The verdict
Anest holds 38 US patents across 16 technology areas, rank #8,329 of 50,000 tracked assignees.
Anest Iwata Corporation has been granted 38 US utility patents between 2015 and 2022, placing Anest Iwata Corporation at rank #8,329 across all assignees tracked by PlainPatent. This portfolio spans 16 distinct Cooperative Patent Classification (CPC) subclasses, averaging 4.5 claims per patent with primary concentration in F04C (ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS ; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS). As a Foreign Corporation, Anest Iwata Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Anest sits between ATOP S.p.a. (38 patents, rank #8,325) and Banner LIFE Sciences Llc (38 patents, rank #8,333) - the closest US assignees by grant volume. The composite Innovation Score of 30.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 36 in the 2015–2019 window, a -94% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Anest Iwata Corporation's 4.5 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 16 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Anest Iwata Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ATOP S.p.A.
38 patents
ATT Southern Inc.
38 patents
AUCTANE, INC.
38 patents
All Purpose Networks, Inc.
38 patents
Apotex Inc.
38 patents
Aqua-Leisure Industries, Inc.
38 patents
Aurea Software, Inc.
38 patents
BANNER LIFE SCIENCES LLC
38 patents
Anest Iwata Corporation
38 patents
What this shows Anest holds 38 patents at rank #8,329, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #8,329 in granted patent volume.
Other assignees with the most granted patents in Anest's primary technology class.
Anest's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
31 Top 64% higher than 36% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 10.5% |
| 2016 | 15 | 39.5% |
| 2017 | 7 | 18.4% |
| 2018 | 6 | 15.8% |
| 2019 | 4 | 10.5% |
| 2020 | 1 | 2.6% |
| 2022 | 1 | 2.6% |
Top 15 of 16 technology areas
Overall rank by patents
#8,329
Across all tracked assignees
30.9 out of 100
How to use this portfolio
Anest's 38 grants land it in the top 64% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.